9 Sep 2024 09:00 - 09:30 Symposium Not recorded Opening speech Hugues de Thé, Lise Alter & Matthieu Resche-Rigon First International THEMA Leukemia Symposium 9 Sep 2024 09:00 - 09:30 Share Facebook LinkedIn Bluesky Threads Copy url Audio-visual RSS
Monday 9 September 2024 Amphithéâtre Marguerite de Navarre, Site Marcelin Berthelot Open to all 09:00 - 09:30 Speaker(s) Hugues de Thé Professor at the Collège de France Events Previous Symposium 9 Sep 2024 09:00 - 09:30 Hugues de Thé, Lise Alter & Matthieu Resche-Rigon Opening speech Not recorded Symposium 9 Sep 2024 09:30 - 09:50 Andreas Trumpp Therapy Response and Resistance of AML Stem Cells to Venetoclax Symposium 9 Sep 2024 10:00 - 10:20 Andrew Lane Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling Symposium 9 Sep 2024 10:30 - 10:50 Alexandre Puissant Overcoming Therapy Resistance in Acute Myeloid Leukemia Symposium 9 Sep 2024 11:10 - 11:40 Nina Cabezas Regulation of Hematopoietic Stem Cell Dormancy Symposium 9 Sep 2024 11:40 - 12:00 Lina Benajiba Unmasking Myeloproliferative Neoplasms Transformation Paths Symposium 9 Sep 2024 12:05 - 12:30 Clemens Schmitt AML State-Switched Not recorded Symposium 9 Sep 2024 14:30 - 14:55 Marc Raaijmakers Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML Symposium 9 Sep 2024 14:55 - 15:20 Diana Passaro Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia Not recorded Symposium 9 Sep 2024 15:20 - 15:40 David Michonneau Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun… Symposium 9 Sep 2024 16:00 - 16:20 Emmanuel Raffoux Quality of Life Matters: A patient perspective Symposium 9 Sep 2024 16:20 - 16:45 Courtney DiNardo AML Therapy in 2024: increasingly individualized approaches Symposium 9 Sep 2024 16:45 - 17:05 Olivier Kosmider VEXAS Syndrome in 2024 Symposium 9 Sep 2024 17:05 - 17:30 Régis Peffault de Latour Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl… Symposium 10 Sep 2024 09:00 - 09:25 Lars Velten Tracking Human Hematopoietic Stem Cell Clones in Health and Disease Symposium 10 Sep 2024 09:25 - 09:50 Emmanuelle Clappier Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia Symposium 10 Sep 2024 09:50 - 10:15 Guillaume Andrieu From Metabolic Vulnerabilities to Targeted Therapies in Leukemia Symposium 10 Sep 2024 10:15 - 10:40 Anindita Roy Developmental Origins of Childhood Leukemia: why does it matter? Symposium 10 Sep 2024 11:00 - 11:25 Timothy Ley AML: Lessons from the Genome Not recorded Symposium 10 Sep 2024 11:25 - 11:50 Ruud Delwel Targeting Evil Enhancers and Genes in AML Symposium 10 Sep 2024 11:50 - 12:20 Raphael Itzykson Targeting Cystine Import in AML Symposium 10 Sep 2024 13:50 - 14:15 Keisuke Ito Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor… Symposium 10 Sep 2024 14:15 - 14:40 Bethan Psaila Targeting Microenvironmental Drivers of Blood Malignancies Not recorded Symposium 10 Sep 2024 14:40 - 15:10 Lionel Adès Any Crosstalk in the Treatment of AML and HR-MDS Symposium 10 Sep 2024 15:30 - 15:50 Marie Sebert Clonal Evolution of Genetic Predisposition to Hematological Malignancies Symposium 10 Sep 2024 15:50 - 16:15 Domitille Rérolle PML Unravels New Insights into the Bases of AML Chemotherapy Response Symposium 10 Sep 2024 16:15 - 16:40 Paresh Vyas Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation Next See also Hugues de Thé, chair Cellular and Molecular Oncology First International THEMA Leukemia Symposium
Symposium 9 Sep 2024 09:00 - 09:30 Hugues de Thé, Lise Alter & Matthieu Resche-Rigon Opening speech Not recorded
Symposium 9 Sep 2024 09:30 - 09:50 Andreas Trumpp Therapy Response and Resistance of AML Stem Cells to Venetoclax
Symposium 9 Sep 2024 10:00 - 10:20 Andrew Lane Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling
Symposium 9 Sep 2024 10:30 - 10:50 Alexandre Puissant Overcoming Therapy Resistance in Acute Myeloid Leukemia
Symposium 9 Sep 2024 11:40 - 12:00 Lina Benajiba Unmasking Myeloproliferative Neoplasms Transformation Paths
Symposium 9 Sep 2024 14:30 - 14:55 Marc Raaijmakers Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML
Symposium 9 Sep 2024 14:55 - 15:20 Diana Passaro Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia Not recorded
Symposium 9 Sep 2024 15:20 - 15:40 David Michonneau Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun…
Symposium 9 Sep 2024 16:20 - 16:45 Courtney DiNardo AML Therapy in 2024: increasingly individualized approaches
Symposium 9 Sep 2024 17:05 - 17:30 Régis Peffault de Latour Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl…
Symposium 10 Sep 2024 09:00 - 09:25 Lars Velten Tracking Human Hematopoietic Stem Cell Clones in Health and Disease
Symposium 10 Sep 2024 09:25 - 09:50 Emmanuelle Clappier Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia
Symposium 10 Sep 2024 09:50 - 10:15 Guillaume Andrieu From Metabolic Vulnerabilities to Targeted Therapies in Leukemia
Symposium 10 Sep 2024 10:15 - 10:40 Anindita Roy Developmental Origins of Childhood Leukemia: why does it matter?
Symposium 10 Sep 2024 13:50 - 14:15 Keisuke Ito Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor…
Symposium 10 Sep 2024 14:15 - 14:40 Bethan Psaila Targeting Microenvironmental Drivers of Blood Malignancies Not recorded
Symposium 10 Sep 2024 15:30 - 15:50 Marie Sebert Clonal Evolution of Genetic Predisposition to Hematological Malignancies
Symposium 10 Sep 2024 15:50 - 16:15 Domitille Rérolle PML Unravels New Insights into the Bases of AML Chemotherapy Response
Symposium 10 Sep 2024 16:15 - 16:40 Paresh Vyas Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation
